association between medication use and adverse gastroenterologic events in patients receiving enteral nutrition therapy at a university hospital

Clicks: 246
ID: 244775
2012
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #14 of 51 articles by views in journal of chemical health risks

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Introduction: Enteral Nutrition Therapy (ENT) is considered an important tool for the appropriate maintenance of nutritional conditions. ENT tolerance may be limited due to gastrointestinal (GI) events resulting from formula composition and/or simultaneously administered drug therapies. Aims: To verify the possible association between GI events and drug therapies being administered to patients receiving ENT at a university hospital. Methods: A prospective observational cohort study was conducted. Medical records from 95 patients requiring ENT at the Hospital de Clínicas de Porto Alegre (HCPA) were randomly evaluated until discharge, death, or initiation of oral or parenteral diet occurred. Details of the administered medications and enteral formula, together with the presenting patient disease and digestive manifestations, were recorded by the medical team. Three experienced gastroenterologists evaluated the possible association between the digestive symptoms and the medications employed. The study protocol was approved by the HCPA Research Ethics Committee and patient consent forms were signed. Results: Mean patient age: 65 ± 17 (24-95) years; 94.70% presented with GI events: constipation 70.50%, diarrhea 38.90%, abdominal distension 18.90%, vomiting 16.80%, and pulmonary aspiration 1.10%. ENT was most indicated in neurologic (50.50%) and neoplastic (25.30%) disease. Medications given to the patients showed a positive relation: 63.20% to 86.70% of GI symptoms could be attributed to the drugs being administered. Conclusions: GI complications during ENT are common; they are frequently linked to administered drug therapy. Health care teams should consider all risk factors present, specifically those related to prescribed medication, before modifying/suspending ENT.
Reference Key
catafesta2012revistaassociation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;J. Catafesta;C. Francesconi
Journal journal of chemical health risks
Year 2012
DOI
10.1016/j.rgmx.2012.06.003
URL
http://www.sciencedirect.com/science/article/pii/S0375090612001115
Keywords
enteral nutrition adverse events Gastroenterology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.